Irisin and Cold Urticaria
Irisin has no established role in the pathophysiology or management of cold urticaria. The available evidence shows irisin is a myokine involved in thermoregulation and metabolic responses to cold exposure, but it is not implicated in the immunologic mechanisms underlying cold urticaria 1, 2.
Understanding the Disconnect
Cold urticaria is a mast cell-driven physical urticaria triggered by cold exposure, characterized by wheals and potentially angioedema or anaphylaxis upon rewarming 3. The pathophysiology involves cold-induced formation of autoallergens and IgE-mediated mast cell degranulation with release of histamine and other inflammatory mediators 3.
Irisin, by contrast, is an anti-inflammatory protein primarily studied in metabolic contexts. While one study showed irisin changes during mild cold exposure (20°C), this was related to thermoregulatory thermogenesis and fat oxidation—not urticarial responses 1. The study found irisin inversely related to respiratory quotient, suggesting a metabolic rather than immunologic role. Another review confirms irisin is downregulated in various inflammatory conditions but focuses on metabolic diseases, not urticaria 2.
There is no published evidence linking irisin levels to cold urticaria development, severity, or treatment response.
Evidence-Based Management of Cold Urticaria
First-Line Treatment
- Start with second-generation H1-antihistamines (cetirizine, desloratadine, fexofenadine, levocetirizine, loratadine) taken once daily 4, 5, 6
- Offer at least two different antihistamines as individual responses vary 4
For Inadequate Response
- Increase antihistamine dose up to 4-fold above the licensed recommendation when benefits outweigh risks 4, 6
- Add leukotriene receptor antagonist (zafirlukast or montelukast): combination therapy with cetirizine plus zafirlukast showed superior efficacy compared to either drug alone in severe cases 7
- Consider adding H2-antihistamine for additional control 4
Refractory Cases
- Omalizumab (off-label): anecdotal resolution of cold urticaria has been reported 4
- Short courses of oral corticosteroids (prednisolone 50 mg daily for 3 days) for severe acute episodes 4
Critical Safety Measures
- Cold avoidance is the most effective prophylactic measure 5
- Epinephrine auto-injector (300 μg for adults) should be prescribed for patients at risk of anaphylaxis from cold exposure 4
- Warn patients about swimming in cold water—this can trigger life-threatening systemic reactions 3
Diagnostic Confirmation
- Patient history plus cold stimulation testing (ice cube test) confirms diagnosis 5, 3
- Additional work-up for underlying infections only if history suggests it 3
Key Clinical Pitfalls
Do not pursue irisin testing—it has no diagnostic or therapeutic utility in cold urticaria. The pathophysiology is immunologic (IgE-mediated mast cell activation), not metabolic.
Do not use long-term oral corticosteroids for chronic cold urticaria 4. This is explicitly contraindicated except in very selected cases under specialist supervision.
Do not overlook anaphylaxis risk—cold urticaria can provoke severe systemic reactions requiring emergency epinephrine 4, 5, 3.